Although, prior studies have shown significant association of the NFKB1 polymorphism with carcinoma of urinary bladder, prostate, cervix and nasopharynx [33,45–47], no role of the polymorphism in ESCC susceptibility was found in the present study. Here, NFKB1 is linked to esophageal squamous cell carcinoma.